Salute Lazio - #Coronavirus: Campagna di vaccinazione anti covid19 Regione Lazio Dalle ore 24:00 del 7 gennaio partiranno le prenotazioni per la dose di richiamo (booster) rivolta alla fascia d'età 12 -
![Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study - ScienceDirect Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X22013998-gr3.jpg)
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study - ScienceDirect
![Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study - ScienceDirect Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X22013998-gr2.jpg)
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study - ScienceDirect
![Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study | The BMJ Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study | The BMJ](https://www.bmj.com/content/bmj/376/bmj-2021-069052/F3.large.jpg)
Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study | The BMJ
![Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modelling study - The Lancet Regional Health – Europe Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modelling study - The Lancet Regional Health – Europe](https://www.thelancet.com/cms/attachment/a5d42a69-cf95-4a40-b773-2e8aeac8702e/gr3_lrg.jpg)
Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modelling study - The Lancet Regional Health – Europe
![Vaccines | Free Full-Text | Acceptance of COVID-19 Vaccination in the Elderly: A Cross-Sectional Study in Southern Italy Vaccines | Free Full-Text | Acceptance of COVID-19 Vaccination in the Elderly: A Cross-Sectional Study in Southern Italy](https://pub.mdpi-res.com/vaccines/vaccines-09-01222/article_deploy/html/images/vaccines-09-01222-g001.png?1634815936)
Vaccines | Free Full-Text | Acceptance of COVID-19 Vaccination in the Elderly: A Cross-Sectional Study in Southern Italy
![Vaccines | Free Full-Text | COVID-19 Vaccination Did Not Increase the Risk of Potentially Related Serious Adverse Events: 18-Month Cohort Study in an Italian Province Vaccines | Free Full-Text | COVID-19 Vaccination Did Not Increase the Risk of Potentially Related Serious Adverse Events: 18-Month Cohort Study in an Italian Province](https://www.mdpi.com/vaccines/vaccines-11-00031/article_deploy/html/images/vaccines-11-00031-g001-550.jpg)
Vaccines | Free Full-Text | COVID-19 Vaccination Did Not Increase the Risk of Potentially Related Serious Adverse Events: 18-Month Cohort Study in an Italian Province
![Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modelling study - The Lancet Regional Health – Europe Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modelling study - The Lancet Regional Health – Europe](https://www.thelancet.com/cms/attachment/8e12c621-3ea3-4382-ab8a-bed2220e31e6/gr1.jpg)
Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modelling study - The Lancet Regional Health – Europe
![Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy - eBioMedicine Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy - eBioMedicine](https://www.thelancet.com/cms/asset/0c21bc4d-5f33-44d4-bf2d-e50f06c9fb39/gr1.jpg)